Skip to content

Comparison of effect of 2 doses of dexamethasone as addition to bupivacaine for brachial plexus block in patients undergoing upper limb surgery.

Comparison of Dexamethasone 4mg and 8mg as an Adjuvant to 0.5% Bupivacaine in Supraclavicular Brachial Plexus Block for Upper Limb Surgeries-A Randomised Clinical Study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018538
Enrollment
60
Registered
2019-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: W011- Fall on same level from slipping,tripping and stumbling with subsequent striking against object

Interventions

Intervention1: GROUP 1 : 1.DEXAMETHASONE 4 mg AS AN ADJUVANT TO 0.5% BUPIVACAINE IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK. Control Intervention1: GROUP 2: DEXAMETHASONE 8mg AS AN ADJUVANT TO 0.5% BUP

Sponsors

Dr LAVANYA CHETAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: AMERICAN SOCIETY OF ANAESTHESIOLOGISTS(ASA) 1AND 2. PATIENT UNDERGOING ELECTIVE UPPER LIMB SURGERIES UNDER SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK.

Exclusion criteria

Exclusion criteria: AMERICAN SOCIETY OF ANAESTHESIOLOGISTS(ASA) 3 AND MORE. PATIENT WITH RENAL AND HEPATIC FAILURE,NEUROMUSCULAR AND CARDIOVASCULAR DISEASE. PATIENT WITH PREGNANCY AND HYPERSENSITIVITY TO STUDY DRUG

Design outcomes

Primary

MeasureTime frame
DURATION FOR REQUEST OF FIRST RESCUE ANALGESIATimepoint: number of doses of analgesia required

Secondary

MeasureTime frame
PATIENT SATISFACTION TOTAL ANALGESIC REQUIREMENT IN FIRST 24 HOURSTimepoint: UP TO 24 HOURS

Countries

India

Contacts

Public ContactDr Arjun BK

KEMPEGOWDA INSTITUTE OF MEDICAL SCIENCES

arjun.bg88@gmail.com9972802569

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026